Drugs / Bifidobacterium longum subsp. infantis M-63
Bifidobacterium longum subsp. infantis M-63
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06044376 | May → Nov 2023 | — | Gadjah Mada University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bifidobacterium longum subsp. infantis M-63 | “Formula milk with triple Bifidobacterium strain containing Bifidobacterium longum BB536 (6.9 x 10\^7 CFU/serving), Bifidobacterium breve M16-V (6.9 x 10\^7 CFU/serving),...” NCT06044376 ↗ |
| Modality | Other / unclassified | “triple Bifidobacterium probiotic strain” NCT06044376 ↗ |